Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions

European Cytokine Network

Volumn 15, Issue 3, 2004, Pages 210-216

  Companjen, Arjen ^a   Van Der Wel, Leontine ^a   Van Der Fits, Leslie ^a   Laman, Jon ^a   Prens, Errol ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

IL 18; Interferon ; Psoriasis; Skin inflammation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 18; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL POLARITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; INTERFERON PRODUCTION; KERATINOCYTE; PATHOGENESIS; PROTEIN EXPRESSION; PSORIASIS; PSORIASIS VULGARIS; SKIN DISEASE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; WESTERN BLOTTING;

BLOTTING, WESTERN; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-18; PSORIASIS; RNA, MESSENGER; SKIN;

EID: 6344259982     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG. 1999. The Majority of Epidermal T Cells in Psoriasis Vulgaris Lesions can Produce Type 1 Cytokines, Interferon-gamma, Interleukin-2, and Tumor Necrosis Factor-alpha, Defining TC1 (Cytotoxic T Lymphocyte) and TH1 Effector Populations: 1 a Type 1 Differentiation Bias is also Measured in Circulating Blood T Cells in Psoriatic Patients. J Invest Dermatol. 113: 752.
2. Prinz JC. 2003. T cells in psoriasis. Exp Dermatol. 12: 919.
3. Nickoloff BJ, Wrone-Smith T. 1999. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol. 155: 145.
4. Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, Meyer zum Buschenfelde KH, Fleischer B. 1994. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol. 102: 145.
5. Uyemura K,Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ. 1993. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol. 101: 701.
6. Denfeld RW, Hollenbaugh D, Fehrenbach A, Weiss JM, von Leoprechting A, Mai B, Voith U, Schopf E, Aruffo A, Simon JC. 1996. CD40 is functionally expressed on human keratinocytes. Eur J Immunol. 26: 2329.
7. Wei L, Debets R, Hegmans JJ, Benner R, Prens EP. 1999. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production. J Pathol. 187: 358.
8. Carroll JM, Crompton T, Seery JP, Watt FM. 1997. Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invent Dermatol. 108: 412.
9. Gracie JA, Robertson SE, McInnes IB. 2003. Interleukin-18. J Leukoc Biol. 73: 213.
10. Stoll S, Muller G, Kurimoto M, Saloga J, Tanimoto T, Yamauchi H, Okamura H, Knop J, Enk AH. 1997. Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol. 159: 298.
11. Mee JB, Alam Y, Groves RW. 2000. Human keratinocytes constitutively produce but do not process interleukin-18. Br J Dermatol. 143: 330.
12. Naik SM, Cannon G, Burbach GJ, Singh SR, Swerlick RA, Wilcox JN, Ansel JC, Caughman SW. 1999. Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene. J Invest Dermatol. 113: 766.
13. Companjen AR, van der Velden VH, Vooys A, Debets R, Benner R, Prens EP. 2000. Human keratinocytes are major producers of IL-18: predominant expression of the unprocessed form. Eur Cytokine Netw. 11: 383.
14. Gardella S, Andrei C, Poggi A, Zocchi MR, Rubartelli A. 2000. Control of interleukin-18 secretion by dendritic cells: role of calcium influxes. FEBS Lett. 481: 245.
15. Gardella S, Andrei C, Costigliolo S, Olcese L, Zocchi MR, Rubartelli A. 2000. Secretion of bioactive interleukin-1beta by dendritic cells is modulated by interaction with antigen specific T cells. Blood. 95: 3809.
16. Koizumi H, Sato-Matsumura KC, Nakamura H, Shida K, Kikkawa S, Matsumoto M, Toyoshima K, Seya T. 2001. Distribution of IL-18 and IL-18 receptor in human skin: various forms of IL-18 are produced in keratinocytes. Arch Dermatol Res. 293: 325.
17. Kaser A, Kaser S, Kaneider NC, Enrich B, Wiedermann CJ, Tilg H. 2004. Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression. Blood. 103: 648.
18. Kawase Y, Hoshino T, Yokota K, Kuzuhara A, Kirii Y, Nishiwaki E, Maeda Y, Takeda J, Okamoto M, Kato S, Imaizumi T, Aizawa H, Yoshino K. 2003. J Invest Dermatol. 121: 502.
19. Yawalkar N, Limat A, Brand CU, Braathen LR. 1996. Constitutive expression of both subunits of interleukin-12 in human keratinocytes. J Invest Dermatol. 106: 80.
20. Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, Dhodapkar M, Krueger JG. 2004. Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris. J Exp Med. 199: 125.
21. Debets R, Hegmans JP, Croughs P, Troost RJ, Prins JB, Benner R, Prens EP. 1997. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol. 158: 2955.
22. Van der Velden VH, Naber BA, van der Spoel P, Hoogsteden HC, Versnel MA. 1998. Cytokines and glucocorticoids modulate human bronchial epithelial cell peptidases. Cytokine. 10: 55.
23. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 106: 761.
24. Laemmli, UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680.
25. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Anna Rev Immunol. 19: 423.
26. Ohta Y, Hamada Y, and Katsuoka K. 2001. Expression of 1L-18 in psoriasis. Arch Dermatol Res. 293: 334.
27. Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF Jr, Foley E, Moskaluk CA, Bickston SJ, Cominelli F. 1999. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol. 162: 6829.
28. Nylander-Lundqvist E, Egelrud T. 1997. Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum comeum chymotryptic enzyme in vitro. Acta Derm Venereol. 77: 203.
29. Lundqvist EN, Companjen AR, Prens EP, Egelrud T. 1998. Biological activity of human epidermal interleukin-1beta: comparison with recombinant human interleukin-1beta. Eur Cytokine Netw. 9: 41.
30. Schonbeck U, Mach F, Libby P. 1998. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-I-independent pathway of IL-1 beta processing. J Immunol. 161: 3340.
31. Sugawara S, Uehara A, Nochi T, Yamaguchi T, Ueda H, Sugiyama A, Hanzawa K, Kumagai K, Okamura H, Takada H. 2001. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol{/roman. 167: 6568.
32. Pol A, Pfundt R, Zeeuwen P, Molhuizen H, Schalkwijk J. 2003. Transcriptional regulation of the elafin gene in human keratinocytes. J Invest Dermatol. 120: 301.
33. Young JL, Sukhova GK, Foster D, Kisiel W, Libby P, Schonbeck U. 2000. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med. 191: 1535.
34. Razmara M, Srinivasula SM, Wang L, Poyet JL, Geddes BJ, DiStefano PS, Bertin J, Alnemri ES. 2002. CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis. J Biol Chem. 277: 13952.
35. Druilhe A, Srinivasula SM, Razmara M, Ahmad M, Alnemri ES. 2001. Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ. 8: 649.
36. Kim PK, Kwon YG, Chung HT, Kim YM. 2002. Regulation of caspases by nitric oxide. Ann N Y Acad Sci. 962: 42.
37. Leung BP, Culshaw S, Gracie JA, Hunter D, Canetti CA, Campbell C, Cunha F, Liew FY, McInnes IB. 2001. A role for IL-18 in neutrophil activation. J Immunol. 167: 2879.
38. Morel JC, Park CC, Kumar P, Koch AE. 2001. Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NFkappaB activation. Lab Invest. 81: 1371.
39. Ariel A, Novick D, Rubinstein M, Dinarello CA, Lider O, Hershkoviz R. 2002. IL-12 and IL-18 induce MAP kinase-dependent adhesion of T cells to extracellular matrix components. J Leukoc Biol. 72: 192.
40. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE. 2001. Evidence of IL-18 as a novel angiogenic mediator. J Immunol. 167: 1644.
41. Wollenberg A, Wagner M, Gunther S, Towarowski A, Tuma E, Moderer M, Rothenfusser S, Wetzel S, Endres S, Hartmann G. 2002. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol. 119: 1096.